Alec Rubio Hinojosa is named as a lobbyist on federal disclosure filings for 1 client through Gsk (fka Glaxosmithkline Inc.). The most recent filing naming them posted in January 2024. Issues reported include Budget/Appropriations, Copyright/Patent/Trademark, Health Issues and Medicare/Medicaid.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Q4 2023 | Copyright/Patent/Trademark, Medicare/Medicaid, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2023 | 1 | 1 |
| 2022 | 1 | 1 |
| 2021 | 1 | 1 |
| 2020 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Alec Rubio Hinojosa. See the Capitol Clarity rankings and method.